product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
CD133
catalog :
3663
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
A3G6K
reactivity :
human
application :
western blot, immunocytochemistry
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; 1:200; loading ...; fig 8b
  • western blot; human; 1:2000; loading ...; fig 5e
Zhou A, Lin K, Zhang S, Chen Y, Zhang N, Xue J, et al. Nuclear GSK3? promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22. Nat Cell Biol. 2016;18:954-966 pubmed publisher
  • western blot; human; loading ...; fig 2
Ayadi M, Bouygues A, Ouaret D, Ferrand N, Chouaib S, Thiery J, et al. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors. Oncotarget. 2015;6:18518-33 pubmed
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.